Why Amgen AMGN is a Top Value Stock for the Long-Term

November 28, 2024

Amgen Inc. (AMGN) has established itself as a top value stock for the long-term, according to financial experts. With its strong focus on innovation and a diverse portfolio, Amgen has proven its ability to deliver consistent growth in the biotechnology industry. The company's recent acquisition of rival drug maker, Otezla, has further strengthened its position in the market. Additionally, Amgen's robust pipeline of new drug candidates and ongoing commitment to research and development make it an attractive investment opportunity. Investors are recommended to seek professional advice, such as that from Stocks Prognosis, to get an accurate forecast of Amgen's stock movement.

Find out how the AMGEN INC. rate is expected to change

Get Forecast for AMGN

Investor opinions & comments:

I've been following Amgen for a while now and their commitment to research and development is impressive. It's definitely a long-term investment option

— from SamuelNelson at 12-01-2024 22:10

I'm excited about Amgen's acquisition of Otezla. It shows the company's strategic thinking and desire to expand its market presence

— from EliWells at 12-01-2024 18:14

This is great news! Amgen seems like a solid investment with its focus on innovation and diverse portfolio

— from CharlesGrant at 12-01-2024 14:49

Amgen's strong focus on innovation and its diverse portfolio make it a top value stock. I'm confident in its long-term potential

— from AubreyCook at 12-01-2024 06:31

I've been following Amgen for a while and their stock has consistently performed well. I'm confident in its long-term prospects

— from CapitalCathy at 11-30-2024 20:44

Amgen's robust pipeline of new drug candidates is very promising. I believe it will contribute to their long-term success

— from FinanceDave at 11-30-2024 18:47

I'm skeptical about Amgen's ability to consistently deliver growth. How can we be certain that their new drug candidates will be successful?

— from JustinMitchell at 11-30-2024 03:47

I'm not so sure about investing in the biotechnology industry. The market is highly volatile and there are always risks involved

— from MeganMason at 11-30-2024 01:15

I trust the financial experts' recommendation. Amgen seems like a solid investment with its consistent growth and commitment to R&D

— from VictoriaKelley at 11-29-2024 21:37

I've heard great things about Amgen's commitment to research and development. It's definitely a stock to consider for long-term investment

— from InvestorImogen at 11-29-2024 12:52

I've heard about Amgen's recent acquisition, it definitely adds value to the company. I'm considering investing in their stock

— from FinanceFiona at 11-29-2024 05:43

Amgen's strong position in the biotechnology industry and its recent acquisition make it an attractive investment opportunity

— from BenjaminParker at 11-29-2024 04:59

Amgen's recent acquisition might have strengthened its position, but it also comes with integration risks. It's important to be cautious

— from SaraBrown at 11-28-2024 15:14

If you want to leave a comment, then you need Login or Register

Other news for AMGN

April 22, 2025Amgen Inc. AMGN: Among the Innovative Healthcare Stocks to Watch in 2025 ~2 min.

Amgen Inc., a leading biotechnology company, is currently one of the most promising stocks in the healthcare sector....

March 20, 2025Hedge Funds Recommend Amgen Inc. AMGN as the Best Pharma Stock to Buy ~1 min.

According to recent reports, hedge funds are strongly recommending Amgen Inc. (AMGN) as the best pharma stock to buy....

March 19, 2025Amgen Inc. AMGN: Cutting-Edge Biotech Company Dominates Stock Market ~2 min.

Amgen Inc. (AMGN), renowned for its groundbreaking innovations in biotechnology, continues to make headlines as a leading player in the stock market....

March 17, 2025Amgen Inc. Continues to Impress Hedge Funds with Strong Performance ~2 min.

Amgen Inc. (NASDAQ:AMGN) has emerged as the top choice for hedge funds looking to invest in the pharmaceutical sector....

March 16, 2025Amgen Inc. AMGN: Discover Why it's Among the Top Pharma Stocks to Buy ~2 min.

Amgen Inc., a leading biotechnology company, has been gaining attention in the investment community due to its outstanding performance in the pharmaceutical sector....

Related news

November 27, 2024Daiwa Securities Group Inc. Buys 12932 Shares of Amgen Inc. ~2 min.

Amgen Inc., a leading biotechnology company, has recently welcomed a significant investment from Daiwa Securities Group Inc....

November 19, 2024Amgen Inc: A Leading Biotechnology Company with Promising Opportunities for Investors ~2 min.

Amgen Inc, also known as AMGN, is a renowned biotechnology company that has been capturing the attention of investors worldwide....

December 20, 2024AbbVie ABBV to Acquire Nimble Therapeutics Further Strengthening Immunology Pipeline ~1 min.

AbbVie Inc. (NYSE: ABBV) has announced its plans to acquire Nimble Therapeutics, a biotechnology company specializing in antibody drug discovery....

November 24, 2024Amgen Inc. Continues to Lead in Immunotherapy: Experts Recommend Investing in Stocks Prognosis ~2 min.

Amgen Inc. (NASDAQ: AMGN) has established itself as a frontrunner in immunotherapy research and development, making it a promising investment opportunity for shareholders....

November 10, 2024Consolidated Planning Corp Buys 1842 Shares of Amgen Inc. NASDAQ:AMGN ~2 min.

Consolidated Planning Corp, a prominent investment firm, has recently acquired 1842 shares of the pharmaceutical giant Amgen Inc. NASDAQ:AMGN....

Search on StockPrognosis.com

Sections of the site

Why Amgen AMGN is a Top Value Stock for the Long-Term

Find out how the AMGEN INC. rate is expected to change

Investor opinions & comments:

Other news for AMGN

Related news

Stocks-Prognosis.com © 2025